Elise Sepulchre

Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report

A. Botezatu, G. Anton, C. Diaconu, 2023, Frontiers in oncology.